Samsung Bioepis, a business of South Korea-based Samsung BioLogics has outlined data it is presenting at the ongoing congress of the European Academy of Dermato 11 October 2023
The HOPE trial—together with a clinical mechanism of action study—strengthens the case for Lundbeck's Lu AG09222, as additional data highlights the anti-pituita 14 September 2023
The addition of chemotherapy to Tagrisso (osimertinib) extended median progression-free survival by nearly nine months in EGFR-mutated advanced lung cancer in t 11 September 2023
Japan’s Daiichi Sankyo has presented impressive results on patritumab deruxtecan (HER3-DXd), a specifically engineered potential first-in-class HER3 directed an 11 September 2023
Californian antiviral specialist Gilead Sciences has revealed new analyses for its flagship medication Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide 24 July 2023
A new analysis of clinical research into selinexor suggest it could be an effective maintenance therapy for certain people with endometrial cancer. 19 July 2023
Over the last few days, attendees of the ongoing annual meeting of the Alzheimer’s Association have been arriving in Amsterdam for what has turned out to be a p 18 July 2023
While targeted protein-busting antibodies are revolutionizing the treatment of Alzheimer’s disease, a damaging side effect - amyloid-related imaging abnormaliti 17 July 2023
At the AAIC in Amsterdam, we’re speaking with two key figures from Lilly's development program for donanemab, as the company presents new data that could help i 17 July 2023
In Alzheimer's, most of the focus has been on the newly-emerging class of intravenous biologics for early-stage disease, and the potential for subcutaneous vers 17 July 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.